TFCP2L1 and breast cancer: In summary, we have shown that phosphorylation of TFCP2L1 at Thr177 by CDK1 is important for ESC pluripotency and cell cycle processes, and that its aberrant activation in adult bladder tissue is associated with tumor progression and poor prognosis of BC.